332 related articles for article (PubMed ID: 29778981)
21. Investigating the relationship between nanomaterial hazard and physicochemical properties: Informing the exploitation of nanomaterials within therapeutic and diagnostic applications.
Johnston H; Brown D; Kermanizadeh A; Gubbins E; Stone V
J Control Release; 2012 Dec; 164(3):307-13. PubMed ID: 22940205
[TBL] [Abstract][Full Text] [Related]
22. Understanding biophysicochemical interactions at the nano-bio interface.
Nel AE; Mädler L; Velegol D; Xia T; Hoek EM; Somasundaran P; Klaessig F; Castranova V; Thompson M
Nat Mater; 2009 Jul; 8(7):543-57. PubMed ID: 19525947
[TBL] [Abstract][Full Text] [Related]
23. The nanoparticle biomolecule corona: lessons learned - challenge accepted?
Docter D; Westmeier D; Markiewicz M; Stolte S; Knauer SK; Stauber RH
Chem Soc Rev; 2015 Oct; 44(17):6094-121. PubMed ID: 26065524
[TBL] [Abstract][Full Text] [Related]
24. Biocompatibility and nanostructured materials: applications in nanomedicine.
Adabi M; Naghibzadeh M; Adabi M; Zarrinfard MA; Esnaashari SS; Seifalian AM; Faridi-Majidi R; Tanimowo Aiyelabegan H; Ghanbari H
Artif Cells Nanomed Biotechnol; 2017 Jun; 45(4):833-842. PubMed ID: 27247194
[TBL] [Abstract][Full Text] [Related]
25. Challenges facing nanotoxicology and nanomedicine due to cellular diversity.
Akhtar MJ; Ahamed M; Alhadlaq HA
Clin Chim Acta; 2018 Dec; 487():186-196. PubMed ID: 30291894
[TBL] [Abstract][Full Text] [Related]
26. Brave new world revisited: Focus on nanomedicine.
Fadeel B; Alexiou C
Biochem Biophys Res Commun; 2020 Nov; 533(1):36-49. PubMed ID: 32921412
[TBL] [Abstract][Full Text] [Related]
27. Physicochemical properties determine nanomaterial cellular uptake, transport, and fate.
Zhu M; Nie G; Meng H; Xia T; Nel A; Zhao Y
Acc Chem Res; 2013 Mar; 46(3):622-31. PubMed ID: 22891796
[TBL] [Abstract][Full Text] [Related]
28. Characterization of the nano-bio interaction between metallic oxide nanomaterials and freshwater microalgae using flow cytometry.
Rivero Arze A; Manier N; Chatel A; Mouneyrac C
Nanotoxicology; 2020 Oct; 14(8):1082-1095. PubMed ID: 32810409
[TBL] [Abstract][Full Text] [Related]
29. Understanding the immunological interactions of engineered nanomaterials: Role of the bio-corona.
Fadeel B
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Nov; 14(6):e1798. PubMed ID: 36416023
[TBL] [Abstract][Full Text] [Related]
30. Fate of engineered nanomaterials at the human epithelial lung tissue barrier
Lehner R; Zanoni I; Banuscher A; Costa AL; Rothen-Rutishauser B
Front Toxicol; 2022; 4():918633. PubMed ID: 36185318
[TBL] [Abstract][Full Text] [Related]
31. Molecular modeling in structural nano-toxicology: interactions of nano-particles with nano-machinery of cells.
Yanamala N; Kagan VE; Shvedova AA
Adv Drug Deliv Rev; 2013 Dec; 65(15):2070-7. PubMed ID: 23726945
[TBL] [Abstract][Full Text] [Related]
32. Biological Surface Adsorption Index of Nanomaterials: Modelling Surface Interactions of Nanomaterials with Biomolecules.
Chen R; Riviere JE
Adv Exp Med Biol; 2017; 947():207-253. PubMed ID: 28168670
[TBL] [Abstract][Full Text] [Related]
33. Proteomic approach to nanotoxicity.
Matysiak M; Kapka-Skrzypczak L; Brzóska K; Gutleb AC; Kruszewski M
J Proteomics; 2016 Mar; 137():35-44. PubMed ID: 26506535
[TBL] [Abstract][Full Text] [Related]
34. Metal oxide nanomaterials in seawater: linking physicochemical characteristics with biological response in sea urchin development.
Fairbairn EA; Keller AA; Mädler L; Zhou D; Pokhrel S; Cherr GN
J Hazard Mater; 2011 Sep; 192(3):1565-71. PubMed ID: 21775060
[TBL] [Abstract][Full Text] [Related]
35. Insights into eco-corona formation and its role in the biological effects of nanomaterials from a molecular mechanisms perspective.
Liu S; Zhang X; Zeng K; He C; Huang Y; Xin G; Huang X
Sci Total Environ; 2023 Feb; 858(Pt 2):159867. PubMed ID: 36334667
[TBL] [Abstract][Full Text] [Related]
36. Nanotoxicology: advances and pitfalls in research methodology.
Azhdarzadeh M; Saei AA; Sharifi S; Hajipour MJ; Alkilany AM; Sharifzadeh M; Ramazani F; Laurent S; Mashaghi A; Mahmoudi M
Nanomedicine (Lond); 2015; 10(18):2931-52. PubMed ID: 26370561
[TBL] [Abstract][Full Text] [Related]
37. New Strategies in the Design of Nanomedicines to Oppose Uptake by the Mononuclear Phagocyte System and Enhance Cancer Therapeutic Efficacy.
Zhou Y; Dai Z
Chem Asian J; 2018 Nov; 13(22):3333-3340. PubMed ID: 29441706
[TBL] [Abstract][Full Text] [Related]
38. Formation of nano-bio-complex as nanomaterials dispersed in a biological solution for understanding nanobiological interactions.
Xu M; Li J; Iwai H; Mei Q; Fujita D; Su H; Chen H; Hanagata N
Sci Rep; 2012; 2():406. PubMed ID: 22586516
[TBL] [Abstract][Full Text] [Related]
39. Metallomics insights for in vivo studies of metal based nanomaterials.
Wang B; Feng W; Zhao Y; Chai Z
Metallomics; 2013 Jun; 5(7):793-803. PubMed ID: 23775512
[TBL] [Abstract][Full Text] [Related]
40. ITS-NANO--prioritising nanosafety research to develop a stakeholder driven intelligent testing strategy.
Stone V; Pozzi-Mucelli S; Tran L; Aschberger K; Sabella S; Vogel U; Poland C; Balharry D; Fernandes T; Gottardo S; Hankin S; Hartl MG; Hartmann N; Hristozov D; Hund-Rinke K; Johnston H; Marcomini A; Panzer O; Roncato D; Saber AT; Wallin H; Scott-Fordsmand JJ
Part Fibre Toxicol; 2014 Feb; 11():9. PubMed ID: 24521051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
